𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Synthesis of an estradiol glucuronide derivative and investigation of its radiopharmaceutical potential

✍ Scribed by F.Z. Biber; P. Unak; T. Ertay; E.I. Medine; F. Zihnioglu; C. Tascı; H. Durak


Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
298 KB
Volume
64
Category
Article
ISSN
0969-8043

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Synthesis of 17α-ruthenocenyl-17β-oestra
✍ Jie Tang; Siden Top; Anne Vessières; Nicole Sellier; Jacqueline Vaissermann; Gér 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB

The synthesis of 17␣-ruthenocenyl-17␤-oestradiol and results of biochemical tests to determine its suitability as a radiopharmaceutical agent, are reported. 17␣-Ruthenocyl-17␤-oestradiol was obtained, in an overall yield of 29%, by addition of ruthenocenyl-lithium (prepared by treatment of ruthenoce

Synthesis and radiolabelling of Re(CO)3-
✍ Yunfeng Ren; Yanhong Sun; Kangmin Cheng; Guifeng Liu; Yumei Shen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 247 KB

## Abstract __β__‐Elemene, (1__S__, 2__S__, 4__R__)‐(−)‐(1‐methy‐1‐vinyl‐2,4‐diisopropenyl cyclohexane) is an anticancer agent from the __Traditional Chinese Herb Medicinal__. Three novel Re(CO)~3~‐__β__‐elemene derivatives including their radioactive conjugates containing __N__,__N__,__N__ trident

Synthesis of [14C] - and [13C6]-labeled
✍ Bachir Latli; Matt Hrapchak; John A. Easter; Wayne T. Stolle; Karl Grozinger; Dh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 185 KB

## Abstract Tipranavir or Aptivus^®^ is a non‐peptidic protease inhibitor approved for the combination treatment with ritonavir of HIV infection. Tipranavir labeled with radioactive and stable isotopes of carbon was required for drug metabolism (excretion, distribution, and absorption) studies and

Synthesis and evaluation of potential tu
✍ F. C. Hunt; D. J. Maddalena; A. B. McLaren; J. G. Wilson 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 French ⚖ 266 KB

## Abstract To exploit the tissue affinity of compounds for radiopharmaceutical purposes, attachment of chelating groups is usually necessary to facilitate technetium‐99m binding and transport. The chelating group, iminodiacetic acid, previously used to modify lidocaine for hepatobiliary radiophar